Compare CYTK & GDDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | GDDY |
|---|---|---|
| Founded | 1997 | 1997 |
| Country | United States | United States |
| Employees | N/A | 5845 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 11.8B |
| IPO Year | 2004 | 2014 |
| Metric | CYTK | GDDY |
|---|---|---|
| Price | $83.53 | $87.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 16 |
| Target Price | $89.26 | ★ $136.44 |
| AVG Volume (30 Days) | 2.3M | ★ 2.3M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.60 |
| Revenue | ★ $13,368,000.00 | N/A |
| Revenue This Year | $7.37 | $7.94 |
| Revenue Next Year | $310.19 | $6.10 |
| P/E Ratio | ★ N/A | $55.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $32.89 | $71.59 |
| 52 Week High | $88.31 | $174.88 |
| Indicator | CYTK | GDDY |
|---|---|---|
| Relative Strength Index (RSI) | 60.87 | 56.94 |
| Support Level | $59.07 | $80.58 |
| Resistance Level | $88.31 | $93.09 |
| Average True Range (ATR) | 2.93 | 3.50 |
| MACD | 0.38 | 1.24 |
| Stochastic Oscillator | 61.54 | 81.39 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.